While Chinese stocks have slumped this month, they’re still leaders when it comes to year-to-date performance. Biotech funds also dominate a list of top-performing nonleveraged ETFs.
MarketWatch.com - Top Stories, MarketWatch
Tue, 06/30/2015 - 12:00am
While Chinese stocks have slumped this month, they’re still leaders when it comes to year-to-date performance. Biotech funds also dominate a list of top-performing nonleveraged ETFs.